The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, […]
Tag: Pharmaceuticals & Biotech
Myocardial Infarction Treatment Market 2034: Clinical Trials, FDA Approvals, Prevalence, Medication, Therapies, Companies by DelveInsight | Pfizer, Mitsubishi Tanabe Pharma, Bayer, KAI Pharma, etc
Myocardial Infarction Market Myocardial Infarction Companies are Thrombologic ApS, Honya Medical Inc, Boehringer Ingelheim, KU Leuven, Pfizer, Mesoblast, Inc., Beijing Anzhen Hospital, TargeGen, GlaxoSmithKline, Stiftung Institut fuer Herzinfarktforschung, Novartis, Mitsubishi Tanabe Pharma Corporation, Bayer, KAI Pharmaceuticals, Rambam Health Care Campus, Quantum Genomics SA, Hoffmann-La Roche, Egetis Therapeutics, Stempeutics Research Pvt Ltd, Lantheus Medical Imaging, and […]
MAIKONG: Leading Manufacturer of Colonic Machine and Colon Hydrotherapy Machine for Over 20 Years
MAIKONG, a renowned manufacturer of Colonic Machine, Colon Hydrotherapy Machine, and Colonic Cleansing Machine, has been providing innovative and reliable products for over 20 years. With a focus on research, development, and production, MAIKONG has become a trusted name in the industry, offering OEM and ODM services to distributors worldwide. As a leading manufacturer, MAIKONG has a strong […]
Triple-Negative Breast Cancer Market to Observe Stupendous Growth During the Study Period (2020–2034) | DelveInsight
Triple-Negative Breast Cancer Market The triple-negative breast cancer market dynamics are expected to change in the coming years with the upcoming availability of new treatment options and increasing healthcare spending across the 7MM, the treatment scenario is expected to experience significant growth during the forecast period (2024–2034). DelveInsight’s Triple-Negative Breast Cancer Market Insights report includes […]
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, MOA, ROA, and Companies by DelveInsight | Merck, Eisai, Janssen Research, 3D Medicines
Cholangiocarcinoma Clinical Trials As per DelveInsight’s assessment, globally, Cholangiocarcinoma pipeline constitutes 55+ key companies continuously working towards developing 60+ Cholangiocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments. (Albany, USA) “Cholangiocarcinoma Pipeline Insight 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth […]
Frontotemporal Dementia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics, Passage Bio
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Frontotemporal Dementia pipeline constitutes 15+ key companies continuously working towards developing 20+ Frontotemporal Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Frontotemporal Dementia Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the […]
Polymyositis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Argenx, Immunoforge Co. Ltd., Chester Oddis, Kezar Life Sciences, Inc., Mallinckrodt, Merck KGaA, Astellas
The Key Polymyositis Companies in the market include – Argenx, Immunoforge Co. Ltd., Chester Oddis, Kezar Life Sciences, Inc., Mallinckrodt, Merck KGaA, Astellas Pharma Inc, Genentech, Pfizer, Bristol-Myers Squibb, and others. DelveInsight’s “Polymyositis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as […]
ALK-positive Non-Small Cell Lung Cancer Pipeline, Treatment Drugs, Clinical Trials, and Companies 2024
DelveInsight’s, “ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK-positive Non-Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It […]
Exosomes Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, Latest FDA, EMA, and PMDA Approvals | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Exosomes pipeline constitutes 70+ key companies continuously working towards developing 75+ Exosomes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Exosomes Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development […]
Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing
The Key Hypertrophic Cardiomyopathy Companies in the market inlcude – Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing Pharmaceuticals, Rocket Pharmaceuticals, Bristol-Myers Squibb, Novartis, Gilead Sciences, Cytokinetics, Imbria Pharmaceuticals, MyoKardia, Inc., Cytokinetics, Tenaya Therapeutics, Novartis, and others. DelveInsight’s “Hypertrophic Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of […]